|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 9/96 | |
| A61K 38/48 | |||
| A61K 38/36 |
| (11) | Number of the document | 2591099 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11738538.5 |
| Date of filing the European patent application | 2011-07-11 | |
| (97) | Date of publication of the European application | 2013-05-15 |
| (45) | Date of publication and mention of the grant of the patent | 2020-11-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/043597 |
| Date | 2011-07-11 |
| (87) | Number | WO 2012/006633 |
| Date | 2012-01-12 |
| (30) | Number | Date | Country code |
| 201161442055 P | 2011-02-11 | US | |
| 201161467880 P | 2011-03-25 | US | |
| 363183 P | 2010-07-09 | US | |
| 201161491762 P | 2011-05-31 | US | |
| 201161442150 P | 2011-02-11 | US | |
| 363186 P | 2010-07-09 | US | |
| 201161442029 P | 2011-02-11 | US |
| (72) |
SALAS, Joe, US
PETERS, Robert, US
BITONTI, Alan, US
|
| (73) |
Bioverativ Therapeutics Inc.,
225 Second Avenue, Waltham, MA 02451,
US
|
| (54) | CHIMERIC CLOTTING FACTORS |
| CHIMERIC CLOTTING FACTORS |